Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer

Pyruvate kinase M2 (PKM2) regulates glycolysis and oxidative phosphorylation; however, the role of PKM2 in ovarian cancer remains largely unknown. We investigated whether ovarian cancer metabolism could provide insight into the development of therapeutic strategies. We performed immunohistochemical...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Tai-Kuang, Huang, Tien-Shuo, Liao, Yu-Ping, Huang, Rui-Lan, Su, Po-Hsuan, Shen, Hueng-Yuan, Lai, Hung-Cheng, Wang, Yu-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533430/
https://www.ncbi.nlm.nih.gov/pubmed/28753677
http://dx.doi.org/10.1371/journal.pone.0182166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533430/
https://www.ncbi.nlm.nih.gov/pubmed/28753677
http://dx.doi.org/10.1371/journal.pone.0182166

Ejemplares similares